The Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd. has authorized a buyback plan on November 6, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.6 CNY | -0.79% | +1.50% | +19.97% |
May. 13 | Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution | MT |
May. 02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.97% | 3.56B | |
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.